These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6131702)

  • 1. Brain slow potentials (CNV), prolactin, and schizophrenia.
    Rizzo PA; Albani GF; Spadaro M; Morocutti C
    Biol Psychiatry; 1983 Feb; 18(2):175-83. PubMed ID: 6131702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingent negative variation and schizophrenia: a long-term follow-up study.
    Rizzo PA; Spadaro M; Albani GF; Morocutti C
    Biol Psychiatry; 1984 Dec; 19(12):1719-24. PubMed ID: 6151404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evoked visual responses in schizophrenic patients].
    Libiger J; Kuba M; Zapletálek M
    Cesk Psychiatr; 1992 Aug; 88(3-4):148-53. PubMed ID: 1356080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of contingent negative variation (CNV) to the study of schizophrenia].
    Timsit-Berthier M; Abraham P; Verhey F
    Acta Psychiatr Belg; 1985; 85():712-33. PubMed ID: 4096256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingent negative variation: components and scalp distribution in psychiatric patients.
    van den Bosch RJ
    Biol Psychiatry; 1984 Jul; 19(7):963-72. PubMed ID: 6477999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
    Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
    Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
    [No Abstract]   [Full Text] [Related]  

  • 7. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingent negative variation and psychopathology: frontal-central distribution, and association with performance measures.
    van den Bosch RJ
    Biol Psychiatry; 1983 Jun; 18(6):615-34. PubMed ID: 6871299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment refractory schizophrenia].
    Vanelle JM
    Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
    Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial clinical response to neuroleptic treatment and serum prolactin levels in acute schizophrenic psychoses].
    Fuentenebro de Diego F; Cabranes JA; Ramos Brieva J; López Jiménez MR; Santiesteban Requena C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1981; 9(6):499-506. PubMed ID: 6129779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum prolactin levels in chronic schizophrenics].
    Ravalli S; Barone R; Molinaro G; Leone NB
    Minerva Psichiatr; 1987; 28(1):31-4. PubMed ID: 2888003
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methodological aspects of the analysis of the effects of drugs (diazepam and caffeine) on contingent negative variation].
    Heinze HJ; Münte TF; Künkel H; Dickmann K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1985 Jun; 16(2):69-74. PubMed ID: 3930214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in slow cerebral potentials (CNV) subsequent to midazolam administration. Double-blind study].
    Fattaposta F; Floris R; Sanarelli L; Terribile P; Tilia G
    Riv Neurol; 1984; 54(5):289-98. PubMed ID: 6505542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of cognitive psychophysiological studies in a comprehensive approach to schizophrenia (treatment of information and attention capacities in acute-stage schizophrenia)].
    Lembreghts M; Timsit-Berthier M
    Acta Psychiatr Belg; 1993; 93 Spec No():322-42. PubMed ID: 8091994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure.
    Pressler M; Nopoulos P; Ho BC; Andreasen NC
    Biol Psychiatry; 2005 Feb; 57(4):394-8. PubMed ID: 15705355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.